While 2021 is underway, we are looking at some of the scientific interventions that may hugely impact the CBD industry. In particular, exciting cannabis research will most likely be the highlight of the coming year. And who knows, we might stumble upon a fact that will change how everybody looks at cannabis. But that’s a story for another day. So, for now, let’s focus on the scientific efforts that will receive tremendous attention in 2021.
Cannabis and COVID
At the onset of the pandemic, news articles and blogs related to cannabis and COVID began emerging. Some determined the risk of cannabis smoking, while others went on to say that cannabis might actually help treat some of the SARS-CoV-2 symptoms.
Nonetheless, these implications spark the light for further research. And to put things into perspective, here’s a research study that tells you more about medical marijuana and its connection with COVID.
In this study, the researchers used 3D artificial lung tissues to establish whether cannabis can decrease cytokine activities or not. The entire model was an identical replica of the human lungs, and it underwent UV light to decrease the inflammation-causing activities. Later on, in the experiment, seven different types of cannabis extracts were added to the process. And luckily, three out of the seven samples worked in reducing cytokine formation.
Not only this, but the study went on to say that two profound cytokines (TNFα and IL-6) that play a huge role in the development of the virus were completely diminished. Simply put, cannabis was successful in reducing major inflammatory actions that lead to lung irritation.
Besides this, one of the notable facts is that cannabis is widely recognized for its anti-inflammatory properties. In particular, cannabidiol (CBD) and cannabigerol (CBG). These two compounds can help balance your body’s inflammatory response.
CBD for PTSD and Anxiety
It’s a known fact that CBD can relieve anxiety, pain, stress, and symptoms of several other conditions. Decades of research, anecdotal evidence, and studies are live examples. Not only this, but cannabinoids also have the power to nourish the human body. Which, in turn, strengthens the metabolism a person needs to fight bacterial and viral diseases. And the best part is that CBD research has gained momentum because of its therapeutic potential. Luckily we will see more research on cannabidiol and other phytocannabinoids in 2021.
According to sources, 2021 is set to launch a new CBD oil that will help treat panic disorders. In a first of its kind clinical study on cannabis phytocannabinoids for panic attacks, it will be determined whether CBD has the actual potential to treat panic attacks or not.
The specific motive behind the study is to establish whether cannabidiol can slow the symptoms of interceptive fear memory inside the human brain or not. A total of 90 participants will most likely act as subjects. Each one of them will be asked to write down their worst fears on a piece of paper. The subjects will also record their fears through verbal communication for listening and observing.
In the next step, the participants will consume another dose (100gm) of CBD. Then, the same doses will be repeated as a placebo in steps two and three. Once the experiment is over, most likely, the authors of this clinical study will establish the therapeutic efficiency of CBD. Not only this, but they will be able to provide concrete proof through these findings.
Delta 8 THC and Its Effects
Delta 8 THC is one of the most controversial cannabis cannabinoids ever to exist. While some states have already started banning its use, others do not mind a little THC in their CBD. So, it’s a given that this component will definitely receive the attention of researchers and people alike.
In fact, for those who are suffering from mental health problems and stress, taking a minimized dose of THC along with CBD can actually prove beneficial. What many people might fail to understand is that not all THC concentration levels are the same. For example, research studies show that delta 9 THC causes paranoia in patients suffering from anxiety. This might actually mean that delta 8 THC has a major role to fulfill in 2021.
In addition to this, you also have to take note of its characteristics. You see, delta-8 and delta-9 are very similar in structural aspects, but the former has fewer psychotropic effects. One of delta-8’s carbon double bonds lies in a different position as compared to delta-9. As a result, any product rich in delta-8 will give a more clear-headed experience than the ones that get you completely couch-locked.
On top of that, people who take delta-8 instead of delta-9 will also feel its calming and pain-relieving effects without dealing with the head high. So, more scientific research may emerge on the subject of Delta-8-THC. Fingers crossed!
THCP – The New Cannabinoid on the Block
For those who don’t know or remember, in 2019, research regarding tetrahydrocannabiphorol emerged. A group of Italian scientists wrote a report on this cannabinoid and established that this component has more affinity towards natural receptors than THC, CBG, CBN, or CBD.
The study’s authors went on to say that THCP forms a concrete bond with CB1 and CB2 receptors of the endocannabinoid system (ECS). And that’s because its chemical structure has seven alkyl chains in the structure instead of 5.
In other words, THCP is more active than THC – the more the side chains, the better a cannabinoid will interact with the human receptors. However, we do not have rough evidence to prove the efficiency of THCP yet. More studies and detailed research is required to see what this new cannabinoid can do.
Supposedly, we will be able to see a few research papers in 2021. Until then, make sure that you get a medical marijuana card to treat specific conditions with medical cannabis. You can apply online or register under a specific state program to get your MMIC. Rest, check your state rules and look out for more studies on cannabis and its therapeutic use in 2021.